Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection for Endoscopic Therapy of Barrett's Esophagus-related Neoplasia

Gastroenterol Clin North Am. 2015 Jun;44(2):317-35. doi: 10.1016/j.gtc.2015.02.006.

Abstract

A major paradigm shift has occurred in the management of dysplastic Barrett's esophagus (BE) and early esophageal carcinoma. Endoscopic therapy has now emerged as the standard of care for this disease entity. Endoscopic resection techniques like endoscopic mucosal resection and endoscopic submucosal dissection combined with ablation techniques help achieve long-term curative success comparable with surgical outcomes, in this subgroup of patients. This article is an in-depth review of these endoscopic resection techniques, highlighting their role and value in the overall management of BE-related dysplasia and neoplasia.

Keywords: Ablation; Barrett’s esophagus; Dysplasia; EMR; ESD; Endotherapy; Esophageal cancer; Resection.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma / diagnostic imaging
  • Adenocarcinoma / pathology
  • Adenocarcinoma / surgery*
  • Barrett Esophagus / pathology
  • Barrett Esophagus / surgery*
  • Dissection / adverse effects
  • Dissection / methods
  • Endosonography
  • Esophageal Neoplasms / diagnostic imaging
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / surgery*
  • Esophagoscopy / instrumentation
  • Humans
  • Mucous Membrane / surgery*